Research article
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
- † Equal contributors
1 Department of Medicine, McGill University, Montreal, Quebec, Canada
2 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
3 Technology Assessment Unit, McGill University Health Center, Montreal, Quebec, Canada
BMC Cardiovascular Disorders 2010, 10:24 doi:10.1186/1471-2261-10-24
Published: 3 June 2010Additional files
Additional file 1:
QUORUM Checklist. Checklist detailing where the required elements of a thorough meta-analysis, as specified by the Quality of Reporting of Meta-Analyses (QUOROM) guidelines, can be located within the manuscript.
Format: PDF Size: 19KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
Quality Assessment of Included Trials. Quality assessment of randomized controlled trials examining the effect of omega-3 fatty acids on all-cause mortality and restenosis using the Jadad scale.
Format: PDF Size: 11KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
Study and Patient Characteristics. Study and patient characteristics of trials examining the effect of omega-3 fatty acids on all-cause mortality and coronary restenosis.
Format: PDF Size: 40KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 4:
Secondary Cardiovascular Outcomes. Randomized controlled trials reporting secondary cardiovascular outcomes, including arrhythmias, cardiac death, congestive heart failure, implantable cardioverter defibrillator shocks, non-fatal myocardial infarction, stroke, and sudden death.
Format: PDF Size: 42KB Download file
This file can be viewed with: Adobe Acrobat Reader
